BioNano Genomics Inc vs Vale SA — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.66M), while Vale SA trades at $14.5 (market cap $61.97B). The key difference: Vale SA is far larger — about 4536.6× BioNano Genomics Inc's market cap, and Vale SA pays a 8.35% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | VALE | |
|---|---|---|
Market Cap | $13.66M | $61.97B |
Sector | Health | Basic Materials |
52-Week High | $4.92 | $17.82 |
52-Week Low | $1.06 | $9.71 |
Enterprise Value | $16.26M | $78.22B |
Dividend Yield | — | 8.35% |
Trailing returns across standard periods
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →Vale is the world's largest iron ore miner and one of the largest diversified miners, along with BHP and Rio Tinto. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets, with minor contributions from iron ore proxies, including manganese and coal. The base metals division is much smaller, primarily consisting of nickel mines and smelters with a small contribution from copper.
Read more on VALE →